Pancreatic Cancer Research

ResearcherChinese PLA General HospitalNo recent work listed

Master Lu Shi

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers
0
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2016: 1 trial

Trials 1

  1. Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies Principal investigator NCT02961101↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yang Liu · 1 shared trial, 2016 · strength 0.08
  2. Jing Nie · 1 shared trial, 2016 · strength 0.08
  3. Meixia Chen · 1 shared trial, 2016 · strength 0.08
  4. Qian Mei · 1 shared trial, 2016 · strength 0.08
  5. Hejin Jia · 1 shared trial, 2016 · strength 0.08
  6. Master Wenying Zhang · 1 shared trial, 2016 · strength 0.08
  7. Kaichao Feng · 1 shared trial, 2016 · strength 0.08
  8. Jingdan Qiu · 1 shared trial, 2016 · strength 0.08
  9. Yan Zhang · 1 shared trial, 2016 · strength 0.08
  10. Master Chunmeng Wang · 1 shared trial, 2016 · strength 0.08
  11. Master Xiang Li · 1 shared trial, 2016 · strength 0.08
  12. Master Liang Dong · 1 shared trial, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.